Results 231 to 240 of about 5,582,484 (376)

Screening for colorectal cancer in a factory-based population with Fecatest [PDF]

, 1983
F I Lee
openalex   +1 more source

SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1‐Mediated Transactivation of CD47

Advanced Science, EarlyView.
Cancer cell‐intrinsic SMYD3 orchestrates an immunosuppressive microenvironment and impairs the response to PD‐1 blockade by reprogramming immune cells landscape in the tumor microenvironment of clear cell renal cell carcinoma (ccRCC). The immunomodulatory function of SMYD3 is mediated via the SREBP1/CD47 pathway.
Zhengfang Liu, Xiumei Zhao, Maolin Zang, Huiyang Yuan, Xin Qin, Xiaofeng Li, Shuo Zhao, Ruirong Tan, Keqiang Yan, Li Liu, Yidong Fan, Ning Zhang, Benkang Shi, Bo Han, Shouzhen Chen   +14 more
wiley   +1 more source

Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer

, 1982
Hans-Jürgen Staab, F. A. Anderer, A. Hornung, E. Stumpf, Rainer Fischer   +4 more
openalex   +2 more sources

ST6GAL1‐Mediated Sialylation Stabilizes PD‐L1 and Drives Immunosuppressive Tumor Microenvironment in Colorectal Cancer

Advanced Science, EarlyView.
ST6GAL1 plays a critical role in tumor progression and immune regulation in colorectal cancer (CRC). Its depletion significantly suppresses the malignant phenotype of CRC cells and enhances the efficacy of anti‐PD‐L1 therapy. High ST6GAL1 expression promotes an immune‐activated tumor microenvironment (TME), characterized by increased infiltration of ...
Ximo Xu, Jingyi Liu, Wei Qin, Chengsheng Ding, Zhenghao Cai, Duohuo Shu, Hao Zhong, Yanyan Hu, Mengqin Yu, Leqi Zhou, Jianwen Li, Minhua Zheng, Bin Li, Sen Zhang, Xiao Yang, Bo Feng   +15 more
wiley   +1 more source

Targeting KRAS in colorectal cancer (Review). [PDF]

Mol Clin Oncol
Zhang M, Wu D, Tang Y, Zhang L, Zhang S, Li W, Li N, Yan X.   +7 more
europepmc   +1 more source

Cell kinetics and in vitro clonogenicity of primary colorectal cancer: clinicopathological relationships and the implications for chemotherapy. [PDF]

, 1985
G A Trotter, G R Morgan, A. Cooper, N Kirkham, J. M. A. Whitehouse, I Taylor   +5 more
openalex   +1 more source

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Annals of Surgery, 1999
Y. Fong, J. Fortner, Ruth L. Sun, M. Brennan, L. Blumgart   +4 more
semanticscholar   +1 more source

CRCFound: A Colorectal Cancer CT Image Foundation Model Based on Self‐Supervised Learning

Advanced Science, EarlyView.
CRCFound is a self‐supervised learning‐based CT image foundation model for colorectal cancer (CRC). Pretrained on 5137 unlabeled CRC CT images, it learns universal feature representations, enabling efficient adaptation to various clinical tasks. The model demonstrates outstanding performance and generalization across multiple diagnostic and prognosis ...
Jing Yang, Du Cai, Junwei Liu, Zhenfeng Zhuang, Yibin Zhao, Feng‐ao Wang, Chenghang Li, Chuling Hu, Baowen Gai, Yiping Chen, Yixue Li, Liansheng Wang, Feng Gao, Xiaojian Wu   +13 more
wiley   +1 more source

Colorectal Cancer: Therapeutic Approaches and Their Complications. [PDF]

Biomedicines
Adeleke A, Adebayo AS, Agbaje K, Olajubutu O, Adesina SK.   +4 more
europepmc   +1 more source

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.

New England Journal of Medicine, 2009
E. Van Cutsem, C. Köhne, E. Hitre, J. Zaluski, Chung-Rong Chang Chien, A. Makhson, G. D'Haens, T. Pintér, R. Lim, G. Bodoky, J. Roh, G. Folprecht, P. Ruff, C. Stroh, S. Tejpar, M. Schlichting, J. Nippgen, P. Rougier   +17 more
semanticscholar   +1 more source